Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Library of deep-learning image segmentation and outcomes model-implementations.
Apte AP, Iyer A, Thor M, Pandya R, Haq R, Jiang J, LoCastro E, Shukla-Dave A, Sasankan N, Xiao Y, Hu YC, Elguindi S, Veeraraghavan H, Oh JH, Jackson A, Deasy JO. Apte AP, et al. Among authors: haq r. Phys Med. 2020 May;73:190-196. doi: 10.1016/j.ejmp.2020.04.011. Epub 2020 May 1. Phys Med. 2020. PMID: 32371142 Free PMC article.
Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.
Ventin M, Cattaneo G, Arya S, Jia J, Gelmi MC, Sun Y, Maggs L, Ksander BR, Verdijk RM, Boland GM, Jenkins RW, Haq R, Jager MJ, Wang X, Ryeom S, Ferrone CR. Ventin M, et al. Among authors: haq r. Clin Cancer Res. 2024 May 20. doi: 10.1158/1078-0432.CCR-24-0071. Online ahead of print. Clin Cancer Res. 2024. PMID: 38767611
Somatic structural variants drive distinct modes of oncogenesis in melanoma.
Conway JR, Gillani R, Crowdis J, Reardon B, Park J, Han SH, Titchen BM, Benamar M, Haq R, Van Allen EM. Conway JR, et al. Among authors: haq r. J Clin Invest. 2024 May 14:e177270. doi: 10.1172/JCI177270. Online ahead of print. J Clin Invest. 2024. PMID: 38758740 Free article.
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation.
Yaeger R, McKean MA, Haq R, Beck JT, Taylor MH, Cohen JE, Bowles DW, Gadgeel SM, Mihalcioiu C, Papadopoulos KP, Diamond EL, Sturtz KB, Feng G, Drescher SK, Reddy MB, Sengupta B, Maity AK, Brown SA, Singh A, Brown EN, Baer BR, Wong J, Mou TC, Wu WI, Kahn DR, Gadal S, Rosen N, Gaudino JJ, Lee PA, Hartley DP, Rothenberg SM. Yaeger R, et al. Among authors: haq r. Cancer Discov. 2024 Apr 30. doi: 10.1158/2159-8290.CD-24-0024. Online ahead of print. Cancer Discov. 2024. PMID: 38691346
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma.
Buchbinder EI, Cohen JV, Tarantino G, Lian CG, Liu D, Haq R, Hodi FS, Lawrence DP, Giobbie-Hurder A, Knoerzer D, Sullivan RJ. Buchbinder EI, et al. Among authors: haq r. Cancer Res Commun. 2024 May 21;4(5):1321-1327. doi: 10.1158/2767-9764.CRC-24-0036. Cancer Res Commun. 2024. PMID: 38683104 Free PMC article. Clinical Trial.
190 results